Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections

• Автори: Giacomo Stroffolini (Автор), Amedeo De Nicolò (Автор), Alberto Gaviraghi (Автор), Jacopo Mula (Автор), Giuseppe Cariti (Автор), Silvia Scabini (Автор), Alessandra Manca (Автор), Jessica Cusato (Автор), Silvia Corcione (Автор), Stefano Bonora (Автор), Giovanni Di Perri (Автор), Francesco Giuseppe De Rosa (Автор), Antonio D'Avolio (Автор)
• Формат: Книга
• Опубліковано: MDPI AG, 2022-09-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Dalbavancin (DBV) is a lipoglycopeptide approved for the treatment of Gram-positive infections of the skin and skin-associated structures (ABSSSIs). Currently, its off-label use at different dosages for other infections deserves attention. This work aimed to study the clinical effectiveness and tole...